IDHIFA (enasidenib mesylate)
ANTINEOPLASTIC - ISOCITRATE DEHYDROGENASE-2 INHIBITOR (IDH2) · ACUTE MYELOID LEUKEMIA WITH ISOCITRATE DEHYDROGENASE-2 (IDH2) MUTATION
CELGENE/BMS